In concordance with prior studies of fluoropyrimidine cardiotoxicity [16–19], elevations in cTnI above the diagnostic cut-off for myocardial infarction were rare and median plasma cTnI levels remained unchanged during treatment. Here, TNNI3 is linked to myocardial infarction.